HiR+X Therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HiR+X Therapy, covering 2025-03-18 to 2025-03-18. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of HiR+X Therapy for Newly Diagnosed Elderly Patients With DLBCL Intolerant to Chemotherapy [Phase 2]